JFS Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.64M | Sell |
10,506
-52
| -0.5% | -$11.2K | 0.13% | 98 |
|
|
2026
Q1 | $2.3M | Sell |
10,558
-220
| -2% | -$48.8K | 0.13% | 99 |
|
|
2025
Q4 | $2.46M | Buy |
10,778
+484
| +5% | +$110K | 0.14% | 94 |
|
|
2025
Q3 | $2.38M | Buy |
10,294
+279
| +3% | +$56.8K | 0.14% | 97 |
|
|
2025
Q2 | $1.86M | Buy |
10,015
+114
| +1% | +$21.2K | 0.12% | 104 |
|
|
2025
Q1 | $2.07M | Sell |
9,901
-272
| -3% | -$52.9K | 0.14% | 90 |
|
|
2024
Q4 | $1.81M | Sell |
10,173
-9
| -0.1% | -$1.66K | 0.12% | 97 |
|
|
2024
Q3 | $2.01M | Buy |
10,182
+8,661
| +569% | +$1.62M | 0.13% | 95 |
|
|
2024
Q2 | $261K | Sell |
1,521
-146
| -9% | -$24.2K | 0.02% | 212 |
|
|
2024
Q1 | $304K | Sell |
1,667
-132
| -7% | -$22.7K | 0.02% | 200 |
|
|
2023
Q4 | $279K | Buy |
1,799
+87
| +5% | +$12.7K | 0.02% | 198 |
|
|
2023
Q3 | $255K | Buy |
1,712
+269
| +19% | +$39.5K | 0.02% | 193 |
|
|
2023
Q2 | $194K | Sell |
1,443
-90
| -6% | -$13.2K | 0.02% | 219 |
|
|
2023
Q1 | $244K | Sell |
1,533
-337
| -18% | -$51.5K | 0.02% | 194 |
|
|
2022
Q4 | $302K | Sell |
1,870
-69
| -4% | -$10.6K | 0.03% | 180 |
|
|
2022
Q3 | $260K | Sell |
1,939
-65
| -3% | -$9.33K | 0.03% | 190 |
|
|
2022
Q2 | $307K | Buy |
2,004
+191
| +11% | +$29.2K | 0.03% | 173 |
|
|
2022
Q1 | $294K | Buy |
1,813
+216
| +14% | +$31.4K | 0.03% | 193 |
|
|
2021
Q4 | $216K | Buy |
1,597
+311
| +24% | +$36.7K | 0.02% | 216 |
|
|
2021
Q3 | $139K | Buy |
1,286
+386
| +43% | +$44.1K | 0.01% | 259 |
|
|
2021
Q2 | $101K | Buy |
900
+6
| +0.7% | +$676 | 0.02% | 220 |
|
|
2021
Q1 | $97K | Sell |
894
-444
| -33% | -$47.5K | 0.02% | 193 |
|
|
2020
Q4 | $143K | Buy |
1,338
+426
| +47% | +$40.9K | 0.03% | 164 |
|
|
2020
Q3 | $80K | Buy |
912
+1
| +0.1% | +$94 | 0.02% | 196 |
|
|
2020
Q2 | $89K | Sell |
911
-4
| -0.4% | -$352 | 0.02% | 189 |
|
|
2020
Q1 | $70K | Sell |
915
-298
| -25% | -$25.4K | 0.02% | 198 |
|
|
2019
Q4 | $107K | Buy |
1,213
+82
| +7% | +$6.81K | 0.03% | 191 |
|
|
2019
Q3 | $86K | Hold |
1,131
| – | – | 0.02% | 202 |
|
|
2019
Q2 | $82K | Hold |
1,131
| – | – | 0.02% | 200 |
|
|
2019
Q1 | $91K | Sell |
1,131
-35
| -3% | -$2.86K | 0.02% | 189 |
|
|
2018
Q4 | $107K | Sell |
1,166
-97
| -8% | -$8.53K | 0.03% | 166 |
|
|
2018
Q3 | $119K | Buy |
1,263
+82
| +7% | +$7.78K | 0.03% | 183 |
|
|
2018
Q2 | $109K | Buy |
1,181
+13
| +1% | +$1.27K | 0.03% | 185 |
|
|
2018
Q1 | $111K | Hold |
1,168
| – | – | 0.03% | 187 |
|
|
2017
Q4 | $113K | Buy |
1,168
+37
| +3% | +$3.49K | 0.03% | 190 |
|
|
2017
Q3 | $101K | Hold |
1,131
| – | – | 0.03% | 184 |
|
|
2017
Q2 | $82K | Hold |
1,131
| – | – | 0.02% | 186 |
|
|
2017
Q1 | $71K | Hold |
1,131
| – | – | 0.02% | 195 |
|
|
2016
Q4 | $71K | Hold |
1,131
| – | – | 0.02% | 195 |
|
|
2016
Q3 | $71K | Hold |
1,131
| – | – | 0.02% | 204 |
|
|
2016
Q2 | $70K | Sell |
1,131
-34
| -3% | -$2.07K | 0.02% | 224 |
|
|
2016
Q1 | $67K | Buy |
1,165
+34
| +3% | +$1.9K | 0.02% | 207 |
|
|
2015
Q4 | $67K | Hold |
1,131
| – | – | 0.02% | 220 |
|
|
2015
Q3 | $62K | Sell |
1,131
-259
| -19% | -$16.9K | 0.03% | 189 |
|
|
2015
Q2 | $93K | Buy |
1,390
+831
| +149% | +$54.3K | 0.05% | 130 |
|
|
2015
Q1 | $33K | Sell |
559
-211
| -27% | -$12.7K | 0.02% | 218 |
|
|
2014
Q4 | $50K | Sell |
770
-3,451
| -82% | -$218K | 0.01% | 185 |
|
|
2014
Q3 | $244K | Sell |
4,221
-563
| -12% | -$31.3K | 0.04% | 67 |
|
|
2014
Q2 | $270K | Sell |
4,784
-2,129
| -31% | -$112K | 0.05% | 66 |
|
|
2014
Q1 | $355K | Sell |
6,913
-4,041
| -37% | -$204K | 0.2% | 70 |
|
|
2013
Q4 | $578K | Buy |
10,954
+803
| +8% | +$39.5K | 0.25% | 65 |
|
|
2013
Q3 | $454K | Buy |
+10,151
| New | +$450K | 0.21% | 69 |
|
Other funds holding ABBV
JFS Wealth Advisors's ABBV Position: Q2 2026 in Review
JFS Wealth Advisors reduced its AbbVie (ABBV) stake by 0.49% in Q2 2026, selling an estimated $11.2K and leaving 10,506 shares worth $2.64M. The position accounts for 0.13% of the portfolio, ranked #98.
JFS Wealth Advisors first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- JFS Wealth Advisors held 10,506 shares of AbbVie worth $2.64M as of Q2 2026.
- JFS Wealth Advisors sold 52 AbbVie shares in Q2 2026, an estimated $11.2K.
- AbbVie made up 0.13% of JFS Wealth Advisors's portfolio in Q2 2026, its #98 holding.
- JFS Wealth Advisors first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.